Search Results - "Ameen, Reem M."

COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study by Alsharidah, Sondas, Ayed, Mariam, Ameen, Reem M., Alhuraish, Fatma, Rouheldeen, Najat A., Alshammari, Farah R., Embaireeg, Alia, Almelahi, Mariam, Adel, Maitham, Dawoud, Mohammed E., Aljasmi, Mohammad A., Alshammari, Nashmi, Alsaeedi, Abdullah, Al-Adsani, Wasel, Arian, Hussan, Awad, Husain, Alenezi, Humoud A., Alzafiri, Azeez, Gouda, Enas F., Almehanna, Mohammad, Alqahtani, Salem, Alshammari, Abdulrahman, Askar, Medhat Z.

“…•Convalescent plasma as an adjunct treatment in moderate and severe COVID-19 disease.•Clinical improvement in COVID-19 disease following convalescent plasma…”
Get full text

Extranodal lymphoma: a comparative study by AlShemmari, Salem H, Ameen, Reem M, Sajnani, Kamlesh P

“…The incidence of extranodal non-Hodgkin's lymphoma (NHL) is increasing worldwide. The epidemiology of NHL in the Middle East is largely unknown. We evaluated…”
Get more information

Factors Associated with Successful Mobilization of Progenitor Hematopoietic Stem Cells Among Patients with Lymphoid Malignancies by Ameen, Reem M., Alshemmari, Salem H., Alqallaf, Dana

“…This study's main aim was to assess the effect of 2 mobilization regimens (granulocyte colony-stimulating factor [G-CSF] and chemotherapy vs. G-CSF alone) on…”
Get full text

Factors influencing engraftment in autologous peripheral stem cell transplantation. The experience of a local Kuwaiti transplantation center by Alshemmari, Salem H, Ameen, Reem M, Gyrafas, Jan, Alqallaf, Dana A, Sajnani, Kamlesh P

“…To assess factors affecting engraftment among patients with lymphoproliferative disorders treated with high dose-chemotherapy and autologous peripheral blood…”
Get more information

Analysis of Clinical Characteristics and Prognostic Variables of Hodgkin's Lymphoma: A Single Center Experience by ALshemmari, Salem H., Bhat, Ganapathi M., Ameen, Reem M., Sajinani, Kamlesh P., Gyarfas, Jan

“…Background: Hodgkin's disease is a curable malignant disease. Despite advances in the management of this disease entity, there are groups of patients who…”
Get full text

The Use of Gallium-67 Scintigraphy to Monitor Tumor Response Rates and Predict Long-Term Clinical Outcome in Patients with Lymphoma by Tuli, Mahmoud M., Al-Shemmari, Salem H., Ameen, Reem M., Al-Muhanadi, Shihab, Al-Huda, Fawaz Abu, Ballani, Nasser, Khoshi, M., Al-Enezi, Farha, Bajciova, Viera, Mottl, Hubert

“…The aim of this study was to determine whether gallium (Ga)-67 scintigraphy can monitor the treatment response rates and predict the longterm clinical outcome…”
Get full text

Primary Gastrointestinal Non-Hodgkin's Lymphoma: Treatment Outcome by Al-Shemmari, Salem H., Sajnani, Kamlesh P., Ameen, Reem M., Ragheb, Ahmed M.

“…Primary gastrointestinal lymphoma is the most common extranodal presentation of non-Hodgkin's lymphoma. In this retrospective study, all cases of primary…”
Get full text